ReachMD

Episodes 1-15 of 139

• • 

    

    Nicola A. Hanania, MD, MS

    Peer

  • 

    

    Reynold A. Panettieri Jr., MD

    Peer

  1

  

  RestartResume

  Advances in Severe Asthma: Highlights from ACAAI 2019

• • 

    

    Sandhya Khurana, MD

    Peer

  • 

    

    Monica Kraft, MD

    Peer

  1

  

  RestartResume

  Singling Out Severe Asthma: New Breakthroughs in Treatment

• • 

    

    Kristina Montemayor, MD

    Peer

  • 

    

    Natalie E. West, MD

    Peer

  • 

    

    Allison Lambert, MD

    Peer

  2

  

  RestartResume

  Catching Cystic Fibrosis: Key Diagnostic & Management Updates

• • 

    

    Anoop Nambiar, MD

    Peer

  • 

    

    Joshua Mooney, MD, MS

    Peer

  0

  

  RestartResume

  Initiating the Right Interstitial Lung Disease Treatment Approach

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Byron M. Thomashow, MD

    Peer

  • 

    

    Barbara Yawn, MD, MSc, FAAFP

    Peer

  2

  

  RestartResume

  Keys to Detecting COPD in the Primary Care Setting

• • 

    

    Reynold A. Panettieri, Jr., MD

    Peer

  • 

    

    Michael E. Wechsler, MD, MMSc

    Peer

  • 

    

    Jonathan Corren, MD

    Peer

  1

  

  RestartResume

  Advances in the Management of Difficult-to-Treat Asthma

• • 

    

    John F. Brandsema, MD

    Peer

  3

  

  RestartResume

  Increasing Awareness and Access to Spinal Muscular Atrophy Therapy

• • 

    

    Shira Johnson, MD

    Peer

  • 

    

    Amy L. Olson, MD, MSPH

    Peer

  • 

    

    Jeffrey Swigris, DO, MS

    Peer

  • 

    

    Katherine Rosen, RN, MSN, ANP-C

    Peer

  2

  

  RestartResume

  Interstitial Pneumonia with Autoimmune Features (IPAF): A Research Classifica...

• • 

    

    Shira Johnson, MD

    Peer

  • 

    

    Amy L. Olson, MD, MSPH

    Peer

  • 

    

    Jeffrey Swigris, DO, MS

    Peer

  • 

    

    Katherine Rosen, RN, MSN, ANP-C

    Peer

  2

  

  RestartResume

  How to Identify & Manage Patients with Progressive-Fibrosing ILD

• • 

    

    Karen L. Reckamp, MS, MD

    Peer

  • 

    

    Mark A. Socinski, MD

    Peer

  • 

    

    Helena Yu, MD

    Peer

  4

  

  RestartResume

  Advanced/Metastatic NSCLC Treatment: Advancements for Patients Without Target...

• • 

    

    John J. Russell, MD

    Peer

  • 

    

    Nicola A. Hanania, MD, MS

    Peer

  10

  

  RestartResume

  Cases in Influenza Management: Aggressive Treatment in Older Adults with Como...

• • 

    

    Ricardo León–Bórquez, MD, MSA

    Peer

  • 

    

    Gustavo Alejandro Lyons

    Peer

  1

  

  RestartResume

  Optimizando la Evaluación de los Biomarcadores Desde la Biopsia al Testeo en ...

• • 

    

    Mark A. Socinski, MD

    Peer

  3

  

  RestartResume

  Optimizing Immunotherapy in NSCLC: Updates from Trials on Agents Targeting PD-L1

• • 

    

    R. Preston Mason, PhD

    Peer

  • 

    

    Michael Miller, MD, FACC, FAHA, FNLA

    Peer

  • 

    

    Margo Minissian, PhD, ACNP

    Peer

  • 

    

    James Underberg, MD

    Peer

  • 

    

    Sergio Fazio, MD, PhD

    Peer

  3

  

  RestartResume

  Clinicians Live: New Opportunities to Reduce Residual Risk Beyond Statin Therapy

• • 

    

    John J. Russell, MD

    Peer

  • 

    

    Mark Sundermeyer, MD

    Peer

  1

  

  RestartResume

  The Role of Primary Care in Diagnosing NSCLC

• 1
• 2
• 3
• …
• 9
• 10
• Next